Stockscreener 앱 받기
15.02
1.01%
0.15
시간 외 거래:
15.00
-0.02
-0.13%
전일 마감가:
$14.87
열려 있는:
$14.75
하루 거래량:
5.58M
Relative Volume:
2.08
시가총액:
$3.58B
수익:
$510.17M
순이익/손실:
$146.93M
주가수익비율:
25.08
EPS:
0.599
순현금흐름:
$27.51M
1주 성능:
+0.20%
1개월 성능:
-7.97%
6개월 성능:
-5.59%
1년 성능:
-27.12%
1일 변동 폭
$14.53
$15.15
1주일 범위
$14.53
$16.39
52주 변동 폭
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.02 | 3.54B | 510.17M | 146.93M | 27.51M | 0.599 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors - Yahoo! Finance Canada
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.1%Should You Sell? - MarketBeat
Technical Analysis: Will ADMA Biologics Inc face regulatory challenges2026 Highlights & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Adma Biologics CEO Grossman sells $318k in shares - Investing.com
ADMA Biologics (ADMA) CEO exercises options and sells 21K shares - Stock Titan
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum - MSN
Tech Rally: Will ADMA Biologics Inc face regulatory challenges2026 Price Action Summary & Technical Pattern Alert System - baoquankhu1.vn
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
HighVista Strategies LLC Invests $1.39 Million in ADMA Biologics Inc $ADMA - MarketBeat
First Light Asset Management LLC Buys 117,137 Shares of ADMA Biologics Inc $ADMA - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Recent Share Price Swings - Yahoo Finance
Assessing ADMA Biologics (ADMA) Valuation After Recent Share Price Pullback And Mixed Performance Signals - simplywall.st
Boothbay Fund Management LLC Makes New $11.33 Million Investment in ADMA Biologics Inc $ADMA - MarketBeat
Marathon Capital Management Has $6.84 Million Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by B Group Inc. - MarketBeat
Reassessing ADMA Biologics (ADMA) After Multi Year Surge And Recent Share Price Pullback - simplywall.st
Why the Market Dipped But Adma Biologics (ADMA) Gained Today - Yahoo Finance
WINTON GROUP Ltd Has $1.03 Million Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Magnetar Financial LLC Makes New Investment in ADMA Biologics Inc $ADMA - MarketBeat
Capital Research Global Investors Makes New $47.70 Million Investment in ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Best Momentum Stocks to Buy for March 12th - Yahoo Finance Singapore
New Strong Buy Stocks for March 12th - Yahoo Finance Singapore
Price-Driven Insight from (ADMA) for Rule-Based Strategy - Stock Traders Daily
Insider Selling: ADMA Biologics (NASDAQ:ADMA) COO Sells $157,800.48 in Stock - MarketBeat
ADMA (NASDAQ: ADMA) files Form 144 showing RSU vesting and proposed sales - Stock Titan
ADMA (ADMA) CEO uses 85,951 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (NASDAQ: ADMA) proposes sale of option-exercise shares on 03/09/2026 - Stock Titan
ADMA Biologics (NASDAQ:ADMA) Director Buys $109,690.00 in Stock - MarketBeat
Funds tied to ADMA (NASDAQ: ADMA) director add 14,000 shares - Stock Titan
New ADMA Biologics CFO Puts Focus On Margins And Capital Allocation - Yahoo Finance
Returns Recap: Is ADMA Biologics Inc subject to activist investor interestTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Segall Bryant & Hamill LLC Reduces Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Buyback Plan Tests Earnings Story And Valuation Gap - simplywall.st
Legato Capital Management LLC Has $433,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
American Century Companies Inc. Purchases 84,934 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside? - simplywall.st
ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Research - MarketBeat
ADMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript - AOL.com
Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Finviz
Royce & Associates LP Acquires 292,819 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by Rafferty Asset Management LLC - MarketBeat
ADMA Biologics (ADMA) CEO withholds 54,858 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (ADMA) Announces $200M Capital Return Plan for 20 - GuruFocus
ADMA Biologics Announces $200 Mln Capital Return Plan - Nasdaq
ADMA Biologics Launches Major 2026 Capital Return Plan - TipRanks
ADMA Biologics (NASDAQ: ADMA) recently announced a $125 million accelerated share repurchase agreement with JPMorgan. - Bitget
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):